Nortech Systems Incorporated filings document the regulatory record of a Nasdaq-listed electronic manufacturing services company serving medical, medical imaging, aerospace and defense, and industrial markets. Its Form 8-K reports include quarterly results releases, credit-facility agreements, covenant waivers, debt-financing terms and corporate governance updates tied to executive and board changes.
The company’s proxy materials cover annual shareholder meeting matters, including director elections, advisory executive-compensation votes, auditor ratification and equity plan approvals. Filing disclosures also identify its common stock registration on the Nasdaq Capital Market and provide formal records of capital-structure, governance and operating-performance events.
NORTECH SYSTEMS INC (NSYS) director Jose Antonio Peris reported an award of 8,000 Stock Options on March 31, 2026. The options have an exercise price of $12.19 per share, become exercisable on May 1, 2027, and expire on March 31, 2036. After this award, he holds 11,107 shares of Common Stock directly, including 3,438 Restricted Stock Units granted on May 20, 2025 that vest on May 1, 2027. No Rule 10b5-1 trading plan is indicated.
NORTECH SYSTEMS INC (NSYS) director Ryan McManus reported an award of 8,000 Stock Options on March 31, 2026. The options have an exercise price of $12.19 per share, become exercisable on May 1, 2027, and expire on March 31, 2036. After this grant, he holds 14,857 shares of Common Stock directly, including previously granted Restricted Stock Units. No transactions are reported under a Rule 10b5-1 trading plan.
NORTECH SYSTEMS INC (symbol: NSYS) is the issuer of record for a Form 4 filing submitted to the SEC. KUNIN DAVID B reported acquisition or exercise transactions in this Form 4 filing.
NORTECH SYSTEMS INC (NSYS) reported that director and ten percent owner David B. Kunin received a grant of 10,800 stock options on March 31, 2026, exercisable at $12.19 per share starting May 1, 2027 and expiring March 31, 2036. After this grant, he holds 81,162 shares of Common Stock directly, including 4,642 Restricted Stock Units vesting May 1, 2027, and 1,344,066 shares indirectly through Curtis Squire, Inc., over which he shares voting and dispositive power. No Rule 10b5-1 trading plan is reported.
NORTECH SYSTEMS INC (symbol: NSYS) is the issuer of record for a Form 4 filing submitted to the SEC. Fredregill Amy S. reported acquisition or exercise transactions in this Form 4 filing.
NORTECH SYSTEMS INC (NSYS) reported that director Amy S. Fredregill received a grant of 8,000 Stock Options on March 31, 2026, each exercisable at $12.19 per share, becoming exercisable on May 1, 2027 and expiring March 31, 2036. Following this grant, she holds 11,107 shares of Common Stock directly, including 3,438 Restricted Stock Units scheduled to vest on May 1, 2027.
NORTECH SYSTEMS INC (NSYS) director Stacy A. Kruse received a grant of 8,000 stock options on March 31, 2026. These options have an exercise price of $12.19 per share, become exercisable on May 1, 2027, and expire on March 31, 2036. Following this grant, Kruse holds 14,857 shares of Common Stock directly, including 3,438 Restricted Stock Units granted on May 20, 2025 that are scheduled to vest on May 1, 2027. No Rule 10b5-1 trading plan is reported for these transactions.
Nortech Systems Incorporated (NSYS) reported higher sales and a return to profitability for the six months ended June 30, 2026. Net sales rose to $33.5 million for the quarter and $63.9 million year-to-date, up 9.3% and 10.9% from the prior-year periods, driven mainly by strong growth in Medical Device and Medical Imaging markets. For the six-month period, net income improved to $0.3 million from a loss of $1.0 million a year earlier, as gross margin expanded.
Gross profit increased to $10.4 million for the first half of 2026, with gross margin improving to 16.3% from 13.7%, reflecting higher volumes and better manufacturing cost absorption, partially offset by an unfavorable sales mix. Operating income for the first six months was $0.7 million, compared with an operating loss of $0.9 million in the prior-year period, aided by the absence of prior restructuring charges despite higher incentive compensation.
Total assets were $80.0 million and shareholders’ equity $35.5 million at June 30, 2026. The company had $7.9 million of lines of credit and current term debt, supported by a new $15.0 million Associated Bank credit facility and term loan maturing in 2029, with covenant compliance reported. Ninety-day backlog rose to $33.4 million and total backlog to $93.8 million, both higher than a year earlier, signaling continued demand, particularly in Aerospace and Defense.
Nortech Systems Incorporated reported higher revenue for the quarter ended June 30, 2026. Net sales were $33.5 million in Q2 2026, up 9.3% from $30.7 million in Q2 2025, with gross profit rising to $5.7 million and gross profit for the first half of 2026 up 31.5% year over year.
Q2 2026 net income was $316 thousand, or $0.11 per basic share, roughly flat versus $313 thousand, or $0.12 per basic share, a year earlier. For the first six months, net income improved to $282 thousand from a loss of $1.0 million in 2025, and Adjusted EBITDA increased to $1.3 million from $73 thousand. However, Q2 EBITDA and Adjusted EBITDA of $938 thousand declined 12.6% from Q2 2025.
The company highlighted a strong order pipeline, with a 90‑day backlog of $33.4 million and total backlog of $93.8 million as of June 30, 2026, up 20% from a year earlier. Cash and restricted cash totaled $1.7 million, operating cash flow for the first half was a use of $2.4 million, and total assets were $80.0 million against total liabilities of $44.6 million.
Nortech Systems Incorporated reported the results of its annual meeting of shareholders held on May 13, 2026. Shareholders voted on the election of directors to the board.
Each of the six director nominees received strong support, with votes for each candidate around 1.59–1.60 million and only a few thousand votes withheld. There were 401,530 broker non-votes recorded for each nominee, indicating some shares were not voted on the election proposal. As a result, all listed nominees were elected to continue serving on the company’s board of directors.
Nortech Systems Incorporated reported improved first quarter 2026 results. Net sales rose to $30.3 million from $26.9 million in Q1 2025, driven by growth across key end markets. Gross profit increased to $4.7 million from $3.1 million while operating expenses were essentially flat, resulting in income from operations of $47 thousand versus a prior-year loss.
The company’s net loss narrowed sharply to $34 thousand, or $0.01 per basic share, compared with a $1.3 million loss, or $0.48 per share, a year earlier. Adjusted EBITDA turned positive at $350 thousand, compared with a $1.0 million loss. The 90-day backlog reached $31.5 million and total backlog was $90.8 million as of March 31, 2026, and the company closed on $17.2 million of debt financing to support its operations and strategy.
Nortech Systems reported higher sales and sharply improved profitability for the quarter ended March 31, 2026. Net sales rose to $30,316 from $26,895, led by growth in Medical Imaging and Aerospace and Defense.
Gross profit increased to $4,702, lifting gross margin to 15.5% from 11.4%, as plant utilization improved after prior restructuring. The company posted a small net loss of $34, significantly better than the $1,316 loss a year earlier.
Operating cash outflow narrowed to $1,561, while cash and restricted cash ended at $2,208. A new $15,000 Associated Bank revolving credit facility and a $2,200 term loan, maturing in 2029, refinanced the prior revolver and support liquidity. Total backlog climbed to $90,802, up strongly year over year, with particular strength in Aerospace and Defense.